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KEY POINTS
 Complex interplays among host, pathogen, and environment determine the severity of
infection ranging from harmless nasopharyngeal colonization to bacteremia, meningitis,
sepsis, and lethal disease.
 The inflammatory response includes proinflammatory and anti-inflammatory responses in
innate and adaptive immunity. The net proinflammatory state causes endothelial dysfunc-
tion and activation of the hemostatic response.
 Within the wide range of illness severity, deposition of fibrin throughout the microcircula-
tion could result in multiple organ dysfunction, skin grafts/amputation, and death.
 Meningococci hold unique properties to promote adhesion, colonization, and invasion into
the bloodstream.INTRODUCTION
Despite important reductions in the number of cases as a result of vaccination pro-
grams, Neisseria meningitidis (meningococcal) disease is still a major cause of invasive
bacterial infections globally.1,2 Complex interplays among host, pathogen, and environ-
ment determine the severity of disease.3–6 The severity of infection ranges from harm-
less nasopharyngeal colonization to bacteremia, meningitis, sepsis, and lethal disease.
Meningococcemia refers to dissemination of meningococci into the bloodstream
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induce endothelial damage, excessive coagulation, and downregulation of fibrinolysis.
Hence, the delicate balance between coagulation and anticoagulation shifts toward
thrombosis and widespread deposition of fibrin throughout the microcirculation with
thromboembolism contributing to multiple organ dysfunction and eventually death.7
Meningococcal sepsis serves as a unique model to study inflammation and coagu-
lation in sepsis. Because of early recognition of clinical features, such as the charac-
teristic rash and shock syndrome, pathophysiologic processes in the early phase of
sepsis can be studied. In addition, meningococcal disease most commonly occurs
in previously healthy children and the broad spectrum of illness severity enables the
study of risk factors for adverse outcome. Lastly, meningococcal disease is still com-
mon, and thus relevant, in many countries across the world.
In this article, we review the pathogenesis of sepsis, in particular the inflammatory and
hemostatic response in meningococcal sepsis. Reviews on meningococcal sepsis
epidemiology, clinical features, management, and prevention are found elsewhere.8,9INFLAMMATORY RESPONSE IN SEPSIS
The inflammatory response10–12 to infection is characterized by two stages and in-
cludes innate and adaptive immune responses (Fig. 1). The first stage, a proinflamma-
tory response, is initiated by pattern-recognition receptors of the innate immune
system (eg, monocytes, macrophages, neutrophils, and dendritic cells) sensing path-
ogens (pathogen-associated molecular patterns) or stress signals (danger-associated
molecular patterns). This detection leads to an intracellular signaling with activation of
transcription factors, leading to the release of various proinflammatory cytokines (eg,
tumor necrosis factor-a, interleukin-1, interleukin-6) and chemokines that attract even
more immune cells, enhancing phagocytosis. Additionally, proteins of the comple-
ment system (eg, C1q and mannan-binding lectin) bind to the surface of pathogens
and augment their destruction.
These proinflammatory factors also mount a more specific adaptive immune
response, which depends on antigen presentation via major histocompatibility com-
plex molecules to lymphocytes. Two classes of lymphocytes, T cells and B cells,
are responsible for cell-mediated immune responses and antibody responses,
respectively. T cells directly recognize and destroy infected cells, whereas the produc-
tion of antibodies against specific pathogens by B cells provides humoral immunity.
Simultaneous to the proinflammatory response, a systemic inhibition of the immune
system occurs to restore homeostasis.13 The result is that monocytes and macro-
phages have diminished capacity to release proinflammatory cytokines on stimulation
and blood monocytes are reprogrammed with reduced expression of HLA-DR.14,15
Additionally, there is an increase in T-cell apoptosis and release of anti-
inflammatory mediators to counteract continual inflammation. Thus, the innate and
adaptive immune system contribute to sepsis-induced immunosuppression.10
Usually, the combined proinflammatory and anti-inflammatory response is able to
combat the infection, without becoming unbalanced and harmful. However, an exces-
sive proinflammatory response can result in early mortality in sepsis because of car-
diovascular collapse and multiple organ dysfunction. In addition, an extended
release of anti-inflammatory mediators (termed immunoparalysis) can potentially
result in failure to clear primary infections and increases susceptibility to new infec-
tions, resulting in late sepsis mortality.
Meningococcemia is the result of meningococci evading the inflammatory host
response. Pili are present on meningococci cell membrane and play a key role in
Fig. 1. The inflammatory response to sepsis. The inflammatory response includes a proin-
flammatory and an anti-inflammatory response. An initial proinflammatory response is initi-
ated by PAMPs sensed by immune cells (eg, leukocytes and parenchymal cells, endothelial
cells, and platelets) through an assortment of cell-surface and intracellular pattern recogni-
tion receptors (eg, TLRs, NLRs, RLRs, and CLRs). Various proinflammatory cytokines and che-
mokines are released to neutralize the infection. In addition, an anti-inflammatory
compensatory mechanism restrains the initial inflammation, prevents collateral tissue dam-
age, and restores homeostasis. An unbalanced and harmful response may result from pre-
vailing and multiplying of the pathogen despite an activated immune response, leading
to a concurrent excessive inflammation (top right). Extended release of anti-inflammatory
mediators could result in immune suppression (bottom right). CLR, C-type lectin receptors;
DAMPs, danger-associated molecular patterns; DCs, dendritic cells; MDSC, myeloid-derived
suppressor cell; NLR, nucleotide-binding oligomerization domain-like receptors; PAMPs,
pathogen-associated molecular patterns; RLR, retinoic acid–inducible gene-like receptors;
TLRs, Toll-like receptors. (From van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The
immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol.
2017;17(7):407-20; with permission.)
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phagocytic vacuoles and outer membrane proteins.16,17 After invasion into the blood-
stream, the outer membrane is further used to evade the host immune response by
inhibiting phagocytosis.16 Meningococci furthermore possess properties to inhibit
host complement activation by binding of host complement factor H to the meningo-
coccal factor H–binding protein.18,19 Virulence factors of the meningococcal outer
membrane, including outer membrane proteins and surface blebs containing lipopoly-
saccharide, function as endotoxin, and stimulation of various proinflammatory cyto-
kines results in an excessive proinflammatory response.20
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The hemostatic response21–23 is initiated because of endothelial activation and
bystander damage after invasion of the bloodstream and inflammation activation by
meningococci and endotoxins. Subsequently, tissue factor is released and increas-
ingly expressed by endothelial cells (Fig. 2). The tissue factor–factor VII pathway ulti-
mately results in the generation of thrombin, and the conversion of fibrinogen to fibrin.
Meningococci in the bloodstream adhere onto endothelial cells via pili, have the
ability to resist high blood velocities, multiply, and form microcolonies on the apical
surface of the endothelial cells.24 Subsequently, the integrity of the endothelium is
challenged. Invasion of meningococci through the endothelium involves transcellular
and paracellular processes: transcellular, via cell fenestrations or establishment ofFig. 2. The hemostatic response to sepsis. Sepsis results in a net procoagulant state in the
microvasculature by at least three mechanisms. (1) Inflammatory cytokine-initiated activa-
tion of tissue factor generating thrombin (gray). Sepsis is accompanied by inflammation-
induced vessel injury, which exposes tissue factor to blood coagulation factors, resulting
in blood clotting. Tissue factor binds and activates FVII, after which a cascade of proteolytic
reactions results in the formation of FXa, thrombin, and fibrin. (2) Insufficient control of
anticoagulant pathways (orange). The tendency toward thrombosis during sepsis is
augmented by the concurrently compromised activity of the three main anticoagulant path-
ways: antithrombin, TFPI, and the protein C system. Antithrombin is the main inhibitor of
thrombin and FXa, whereas TFPI is the main inhibitor of the tissue factor–FVIIa complex.
Activated protein C is generated from protein C at the surface of resting endothelial cells,
a process that is mediated by the binding of thrombin to TM and is amplified by the
EPCR. Activated protein C proteolytically inactivates the coagulation cofactors FVa and
FVIIIa, thereby inhibiting coagulation. During sepsis, the protein C system is impaired as a
result of multiple factors, most notably the decreased synthesis of protein C by the liver,
the increased consumption of protein C, and the impaired activation of protein C as a result
of diminished TM expression on endothelial cells. (3) PAI-1-mediated suppression of fibrino-
lysis (blue). The interaction with the complement system (green) is outside the scope of this
review. EPCR, endothelial cell protein C receptor; NET, neutrophil extracellular traps; PAI,
plasminogen activator inhibitor; TFPI, tissue factor pathway inhibitor; TM, thrombomodulin;
tPA, tissue-plasminogen activator; uPA, urokinase plasminogen activator . (From van der Poll
T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential ther-
apeutic targets. Nat Rev Immunol. 2017;17(7):407-20; with permission.)
Inflammatory and Hemostatic Response 395complex systems of vesiculovacuolar organelles, and paracellular based on the coor-
dinated opening and closure of endothelial cell–cell junctions.25 These processes also
account for the ability to cross the blood-brain barrier.26 Additionally, there is a direct
interaction between bacteria and endothelial cells leading to a loss of integrity and in-
crease in endothelial permeability.26 As a consequence, histology of skin lesions
reveal bacteria within the endothelium and thrombi.27
In normal circumstances, activation of coagulation is controlled by three important
physiologic anticoagulant pathways: (1) the antithrombin system, (2) tissue factor
pathway inhibitor, and (3) the activated protein C (PC) pathway. The main function
of the PC pathway is to control coagulation by causing inactivation of activated (a) fac-
tor V (cofactor of factor Xa) and factor VIIIa (cofactor of factor IX), subsequently pre-
venting thrombin generation.28 PC also neutralizes plasminogen activator inhibitor
(PAI)-1. PAI-1, encoded by SERPINE1, is produced by endothelial cells. PAI-1 func-
tions as the principal inhibitor of tissue plasminogen activator and urokinase plasmin-
ogen activator, and is the most important fibrinolytic inhibitor in vivo. Thus, PC
concomitantly increases fibrinolytic capacity. Thrombomodulin, an endothelial cell
surface glycoprotein, binds circulating thrombin and forms a thrombomodulin-
thrombin complex (Fig. 3). This complex rapidly activates PC bound to the endothelial
cell PC receptor. Activated PC then dissociates from the endothelial cell PC receptor,
binds to protein S, and forms a complex that inactivates factor Va and factor VIIIa, thus
reducing thrombin generation.
In sepsis, decreased activity of all three natural anticoagulant mechanisms results
from a combination of impaired synthesis, ongoing consumption, leakage into the
interstitial space, and proteolytic degradation. Decreased levels of PC29 and
increased levels of PAI-130,31 are associated with a negative outcome in sepsis. In
meningococcal disease, it has been shown clearly that 4G/4G homozygotes have
higher levels of PAI-1, which is associated with more severe disease.30
Altogether, these mechanisms in patients with sepsis result in coagulation abnor-
malities ranging from subtle derangements only detectable by highly sensitive assays
to widespread deposition of fibrin throughout the microcirculation, manifesting as
disseminated intravascular coagulation, as typically seen in meningococcal sepsis.
Ultimately, disseminated intravascular coagulation contributes to multiple organ
dysfunction and to the need for skin grafts, amputation of digits and extremities,
and can eventually result in death from multiple organ dysfunction.
Genetic polymorphisms or combination of polymorphisms partly determine interin-
dividual variety in the host response to infection and have been associated with sus-
ceptibility and severity of sepsis.4,32 A genome-wide association study, including
approximately 1500 patients with meningococcal disease, reported an association
between polymorphisms in the previously mentioned complement factor H region,
which play a role in complement activation, and susceptibility.19 In adults with sepsis
caused by pneumonia, a genome-wide association study revealed FER, which en-
codes a cytosolic nonreceptor tyrosine kinase that influences neutrophil chemotaxis
and endothelial permeability, to be associated with a reduced risk of death.33 Although
genetic variations have the potential to affect the host response to an infectious chal-
lenge, genetic findings have not been translated to clinical practice.
Neutrophil Extracellular Traps as Cross-link Between Inflammation and
Coagulation
Neutrophils are an important part of the innate immune defense. They migrate to the
site of infection to release regulatory cytokines, chemokines, and leukotrienes to
contribute to microbial killing.34 One of the tools actively contributing to microbial
Fig. 3. The protein C pathway. TM binds circulating thrombin (1) and forms a TM-thrombin
complex, which activates PC bound to EPCR into aPC (2). APC then dissociates from the EPCR,
binds to PS, and forms a complex that inactivates factor Va and factor VIIIa (3). aPC, acti-
vated protein C; EPCR, endothelial cell protein C receptor; IIa, thrombin; PS, protein S;
TM, thrombomodulin. (From Boeddha NP, Emonts M, Cnossen MH, et al. Gene Variations
in the Protein C and Fibrinolytic Pathway: Relevance for Severity and Outcome in Pediatric
Sepsis. Semin Thromb Hemost. 2017;43(1):36-47; with permission.)
Boeddha et al396killing is the release of neutrophil extracellular traps (NETs). NETs are extracellular
DNA matrix, containing granule proteins and histones to degrade virulence factors
and to kill bacteria.35
Although NETs are primarily considered as a protective mechanism because of the
toxicity of antimicrobial components of the NETs, NETs may contribute to disease
severity by causing cell damage via cytotoxic effects of NET-bound histones and by pro-
moting coagulation.36–38 During systemic inflammation in sepsis, NETs or their compo-
nents may damage tissue and endothelia, which then initiates the coagulation cascade.
Inflammatory and Hemostatic Response 397In addition, NETs stimulate platelet adhesion, which may partly account for the throm-
bocytopenia commonly observed in sepsis.39 NETs also promote various procoagulant
and antifibrinolytic processes,38 such as fibrin clot formation, factor XII activation, and
via histones, interaction with thrombomodulin-dependent PC activation leading to
increased thrombin generation. This process named “immunothrombosis” is an impor-
tant link between inflammation and coagulation.40 Ideally, a balance in NETs is needed
to prevent excess thrombin generation, while preserving adaptive hemostasis.
The currently available literature on NETs or components of NETs in sepsis mostly
originates from adult studies or animal studies. Several adult studies demonstrated
increased (derivatives of) NETs during infectious conditions: increased neutrophil
elastase-DNA in patients with pneumonia and nonpulmonary sepsis compared with
critically ill control subjects,41 increased plasma histone and cell free (cf)-DNA levels
in 17 patients with sepsis compared with critically ill patients without sepsis,42
elevated cf-DNA and myeloperoxidase DNA in patients with influenza A viral infec-
tion,43 and higher serum cf-DNA/NETs levels in 31 patients with sepsis compared
with healthy control subjects.36 In a study including 60 children with meningococcal
sepsis, NET levels were higher in the acute phase of disease, that is, at admission
to pediatric intensive care unit and at 24 hours after admission, comparedwith 1month
after admission.44 Most of these studies reported an association between NET levels
and illness severity or mortality.36,41,43 Thus, in the early phase of infection, NETs are
increased and seem to be associated with illness severity.
SUMMARY
This article reviews the inflammatory and hemostatic response in sepsis, illustrating a
complex interplay among host, pathogen, and environmental factors. Meningococci
hold unique properties to promote adhesion, colonization, and invasion into the blood-
stream. The inflammatory host response, including proinflammatory and anti-
inflammatory responses in innate and adaptive immunity, skew toward a proinflamma-
tory state. This leads to endothelial dysfunction and activation of hemostatic
response. Within the wide range of illness severity, deposition of fibrin throughout
the microcirculation could result in multiple organ dysfunction, the need for skin grafts
and amputation, and eventually death.
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